The site of anti-arthritic action of the κ-opioid, U-50,488H, in adjuvant arthritis: Importance of local administration

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1754-1760

  Wilson, Jodie L ^a   Nayanar, Vim ^b   Walker, Judith S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

(+) U 50,488H; ( ) U 50,488H; ( ) U 50,488H; Adjuvant arthritis; Inflammation; MR 2266; Naloxone methiodide; Peripheral effects; agonist; antagonist

Indexed keywords

17 METHYLNALOXONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 5,9 DIETHYL 2 (3 FURYLMETHYL) 2' HYDROXY 6,7 BENZOMORPHAN; KAPPA OPIATE RECEPTOR; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EDEMA; ENANTIOMER; HISTOLOGY; INFLAMMATION; INTRADERMAL DRUG ADMINISTRATION; JOINT DESTRUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RADIOGRAPHY; RAT; RECEPTOR UPREGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029946394     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15601.x     Document Type: Article

References (41)

1. ACKERMAN, E.R., ROOKS, W.H., SHOTT, L., GENANT, H., MALONEY, P. & WEST, E. (1979). Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arth. Rheum., 22, 1365-1373.
2. AHMED, M., BJURHOLM, A. & SRINIVASAN, G.P. (1995a). Capsaicin effects on substance P and CGRP in rat adjuvant arthritis. Regul. Pept., 55, 85-102.
3. AHMED, M., SRINIVASAN, G.R., THEODORSSON, E., SCHULTZBERG, M. & KREICBERGS, A. (1995b). Effects of surgical denervation on substance P and calcitonin gene-related peptide in adjuvant arthritis. Peptides, 16, 569-579.
4. ANTONIJEVIC, I., MOUSA, S.A., SCHAFER, M. & STEIN, C. (1995). Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci., 15, 165-172.
5. BARBER, A. & GOTTSCHLICH, R. (1992). Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation. Med. Res. Rev., 12, 525-562.
6. BASBAUM, A.I. & LEVINE, J.D. (1991). Opiate Analgesia: how central is a peripheral target? N. Engl. J. Med., 325, 1168-1169.
7. BROWN, S.L., TOKUDA, S., SALAND, L.C. & VAN EPPS, D.E. (1986). Opioid peptides effects on leukocyte migration. In Enkephalins and Endorphins Stress and the Immune System, ed. Plotnikoff, N.P., Faith, R.E., Murgo, A.J. & Good, R. pp. 367-386, New York: Plenum Press.
8. CARMODY, J.J. (1987). Opiate receptors: an introduction. Anaesth. Intens. Care., 15, 27-37.
9. COLPAERT, F., DONNERER, J. & LEMBECK, F. (1983). Effects of capsaicin on inflammation and on substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci., 32, 1827-1834.
10. CRUWYS, S.C., GARRETT, N.E. & KIDD, B.L. (1995). Sensory denervation with capsaicin attenuates inflammation and nociception in arthritic rats. Neurosci. Lett., 193, 205-207.
11. CZLONKOWSKI, A., STEIN, C. & HERZ, A. (1993). Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur. J. Clin. Pharmacol., 242, 229-235.
12. DONALDSON, L.F., HARMER, A.J., McQUEEN, D.S. & SECKL, J.R. (1995). Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat. J. Physiol., 486, 473-482.
13. DYKSTRA, L.A., GMEREK, D.E., WINGER, G. & WOODS, J.H. (1987). Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J. Pharmacol. Exp. Ther., 242, 413-20.
14. FERREIRA, S.H. & NAKAMURA, M. (1979). Prostaglandin hyperalgesia II. The peripheral analgesic activity of morphine, enkephalins and opioid antagonists, Prostaglandins, 18, 191-200.
15. HORWELL, D.C. (1988). Kappa opioid analgesics. Drugs Future, 13, 1061-1070.
16. JAFFE, J.H. & MARTIN, W.R. (1994) Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics, ed. Goodman, L.S. & Gilman, A. pp. 485-521, New York: Macmillan Publishing Co., Inc.
17. LEMBECK, F. & DONNERER. J (1985). Opioid control of the function of primary afferent substance P fibres. Eur. J. Pharmacol., 114, 241-246.
18. LEON, A., BURIANI, A., DAL TOSO, R., FABRIS, M., ROMANELLO, S., ALOE, L. & LEVIN-MONTALCINI, R. (1994). Mast cells synthesize, store and release nerve growth factor. Proc. Natl. Acad. Sci. U.S.A., 91, 3739-3743.
19. LEVINE, J.D., COLLIER, D.H., BASBAUM, A.I., MOSKOWITZ, M.A & HELMS, C.A. (1985a). Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis. J. Rheumatol., 12, 406-411.
20. LEVINE, J.D., GOETZL, E.J. & BASBAUM, A.I. (1987). Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum. Dis. Clin. North Am., 13, 369-383.
21. LEVINE, J.D., MOSKOWITZ, M.A. & BASBAUM, A.I. (1985b). The contribution of neurogenic inflammation in experimental arthritis. J. Immunol., 135, 843s-847s.
22. METZLER, C.M., ELFRING, G.L. & McEWEN, A.J. (1974). A users manual for NONLIN and associated programs. Biometrics, 30, 562.
23. MILLAN. M.J. & COLPAERT, F.C. (1991). Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology. Neurosci., 42, 541-553.
24. MOSKOWITZ, M.A., BRODY, M. & LIU-CHEN, L.Y. (1983). In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neurosci., 9, 809-814.
25. PFEIFFER, A., BRANTL, V., HERZ, A. & EMRICH, H.M (1986). Psychomimesis mediated by k-opioid receptors. Science, 233, 774-776.
26. PINCUS, T. (1994). Rheumatoid Arthritis: A medical emergency? Scand. J. Rheumatol., 23, (suppl 100), 21-30.
27. PINCUS, T., MARCUM, S.B. & CALLAHAN, L.F. (1992). Long term therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second-line drugs and prednisone. J. Rheumatol., 19, 1885-1894.
28. ROTHMAN, R.B., FRANCE, C.P., BYKOV, V., DE COSTA, B.R., JACOBSON, A.E., WOODS, J.H & RICE, K.C. (1989). Pharmacological activities of optically pure enantiomers of the kappa-opioid agonist, U-50,488H, and its cis diastereomer: evidence for three kappa-receptor subtypes. Eur. J. Pharmacol., 167, 345-353.
29. RUSSELL, N.S.W., JAMIESON, A., CALLEN, A. & RANCE, M.J. (1985). Peripheral opioid effects upon neurogenic plasma extravasation and inflammation. Br. J. Pharmacol., 84, 788P.
30. SIBINGA, N.E.S. & GOLDSTEIN, A. (1988). Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol., 6, 219-249.
31. STEIN, C. (1991). Peripheral analgesic actions of opioids. J. Pain Sympt. Manag., 6, 119-124.
32. STEIN, C. (1995). The control of pain in peripheral tissue by opioids. N. Engl. J. Med., 332, 1685-1690.
33. STEIN, C., COMISEL, K., HAIMERL, E., YASSOURDIS, A., LEHRBERGER, K., HERZ, A. & PETER, K. (1991). Analgesic effect of intra-articular morphine after arthroscopic knee surgery. N. Engl. J. Med., 325, 1123-1126.
34. STEIN, C., HASSAN, A.H.S., PRZEWLOCKI, R., GRAMSCH, C., PETER, K. & HERZ, A. (1990). Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. U.S.A., 87, 5935-5939.
35. STEIN, C., MILLAN. M.J. & SHIPPENBERG, T.S. (1989). Peripheral opioid receptors mediate antinociception in inflammation. J. Pharmacol. Exp. Ther., 248, 1269-1275.
36. TAUB, D.D., EISENSTEIN, T.K., GELLER, E.B. & ADLER, M.W. (1991). Immunomodulatory activity of mu- and kappa-selective opioid agonists. Proc. Natl. Acad. Sci. U.S.A., 88, 360-364.
37. WALKER, J.S., HOWLETT, C.R. & NAYANAR, V. (1995). Antiinflammatory effects of kappa-opioids in adjuvant arthritis. Life Sci., 57, 371-378.
38. WALKER, J.S. & KASMERSKI, L. (1988). Diflunisal pharmacodynamics in experimental arthritis in rats. J. Rheumatol., 15, 1643-1647.
39. WATKINS, L.R., MAIER, S.F. & GOEHLER, L.E. (1996). Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain, 63, 289-302.
40. WILSKE, K.R. & HEALY, L.A. (1989). Remodelling the pyramid - a concept whose time has come. J. Rheumatol., 16, 565-567.
41. YAKSH, T.L. (1988). Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res., 458, 319-324.